Improved risk stratification in myeloma using a micro RNA‐based classifier
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Multiple myeloma (MM) is a heterogeneous disease. International Staging System/fluorescence hybridization (ISS/FISH)‐based model and gene expression profiles (GEP) are effective approaches to define clinical outcome, although yet to be improved. The discovery of a class of small non‐coding RNA s (micro RNA s, mi RNA s) has revealed a new level of biological complexity underlying the regulation of gene expression. In this work, 163 presenting samples from MM patients were analysed by global mi RNA profiling, and distinct mi RNA expression characteristics in molecular subgroups with prognostic relevance (4p16, MAF and 11q13 translocations) were identified. Furthermore we developed an “outcome classifier”, based on the expression of two mi RNA s (MIR 17 and MIR 886‐5p), which is able to stratify patients into three risk groups (median OS 19·4, 40·6 and 65·3 months, P = 0·001). The mi RNA‐based classifier significantly improved the predictive power of the ISS/FISH approach (P = 0·0004), and was independent of GEP‐derived prognostic signatures (P < 0·002). Through integrative genomics analysis, we outlined the potential biological relevance of the mi RNA s included in the classifier and their putative roles in regulating a large number of genes involved in MM biology. This is the first report showing that mi RNA s can be built into molecular diagnostic strategies for risk stratification in MM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820 · cited 1×
“All of the RNA samples were run in duplicate and normalized on the basis of the expression of MIR103 (Peltier & Latham, 2008).”
BackgroundMicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Pichiorri, F., Suh, S.-S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Taccioli, C., Zanesi, N., Alder, H., Hagan, J. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806202105 · Cited by 563
Cited by
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Berindan‐Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21244 · Cited by 522
Low serum mi R‐19a expression as a novel poor prognostic indicator in multiple myeloma
Hao, M., Zang, M., Wendlandt, E., Xu, Y., An, G., Gong, D., Li, F., Qi, F., Zhang, Y., Yang, Y., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29199 · Cited by 72
Ismail, N. H., Mussa, A., Al-Khreisat, M. J., Mohamed Yusoff, S., Husin, A., Al-Jamal, H. A. N., Johan, M. F., & Islam, M. A. (2023) · Non-Coding RNA · doi:10.3390/ncrna9060068 · Cited by 29
MicroRNAs in B-cells: From normal differentiation to treatment of malignancies
Marques, S. C., Laursen, M. B., Bødker, J. S., Kjeldsen, M. K., Falgreen, S., Schmitz, A., Bøgsted, M., Johnsen, H. E., & Dybkaer, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3057 · Cited by 26
“[142] identified a classifier comprising 2 miRNAs, miR-17 and miR-8865p, that distinguished three subgroups of MM patients with different OS, improving the classification provided by the International Staging System and Fluorescence In-Situ Hybridization-based abnormalities.”
BackgroundMethodLi, F., Hao, M., Feng, X., Zang, M., Qin, Y., Yi, S., Li, Z., Xu, Y., Zhou, L., Sui, W., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.010 · Cited by 25
Metadata
- Authors
- Wu, P., Agnelli, L., Walker, B. A., Todoerti, K., Lionetti, M., Johnson, D. C., Kaiser, M., Mirabella, F., Wardell, C., Gregory, W. M., Davies, F. E., Brewer, D., Neri, A., & Morgan, G. J.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2013-05-30
- Volume
- 162
- Issue
- 3
- Pages
- 348-359
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1990793727
- Cited by
- 58
- References
- 2
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved risk stratification in myeloma using a micro RNA‐based classifier. https://app.cochat.ai/papers/10.1111/bjh.12394
- The paper
- Wu, P., Agnelli, L., Walker, B. A., Todoerti, K., Lionetti, M., Johnson, D. C., Kaiser, M., Mirabella, F., Wardell, C., Gregory, W. M., Davies, F. E., Brewer, D., Neri, A., & Morgan, G. J. (2013). Improved risk stratification in myeloma using a micro RNA‐based classifier. British Journal of Haematology. https://doi.org/10.1111/bjh.12394
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.